In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions

A total of 8,072 gram-positive isolates collected from 69 medical centers among all 9 U.S. Census Divisions during the 2015 SENTRY Antimicrobial Surveillance Program were included. Telavancin had minimal inhibitory concentration (MIC)(50) and MIC(90) values of 0.03/0.06 μg/mL, respectively, against...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaller, Michael A., Sader, Helio S., Flamm, Robert K., Castanheira, Mariana, Smart, Jennifer I., Mendes, Rodrigo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646740/
https://www.ncbi.nlm.nih.gov/pubmed/28727951
http://dx.doi.org/10.1089/mdr.2017.0022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646740/
https://www.ncbi.nlm.nih.gov/pubmed/28727951
http://dx.doi.org/10.1089/mdr.2017.0022

Ejemplares similares